Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

vTv Therapeutics Inc.

TRADE

NASDAQ: VTVTHealthcare / Biotechnology / USA
0.84+0.02+2.44%Vol 69 1971Y Perf -85.52%
Sep 21st, 2018 16:00
BID0.80 ASK0.84
Open0.81 Previous Close0.82
Pre-Market- After-Trading0.75
 - -%  -0.09 -10.71%
Target Price
3.00 
Analyst Rating
Hold 3.00
Potencial %
257.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)29 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.45 
Earnings Date
7th Nov 2018

Today's Price Range

0.800.84

 

52wk Range

0.658.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-29.41%
3 Months
-46.50%
6 Months
-82.54%
1 Year
-85.52%
3 Years
-88.46%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTVT0.840.02002.44
AAPL218.31-1.7200-0.78
GOOG1 166.99-19.8800-1.67
MSFT114.110.54000.48
XOM85.170.35000.41
WFC54.99-0.5600-1.01
JNJ142.880.90000.63
FB163.03-2.9900-1.80
GE12.17-0.2900-2.33
JPM117.85-0.7800-0.66
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.10
Current Ratio 0.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -12.30
Leverage Ratio -0.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-879.40
EBITDA Margin-875.70
Pre-tax Profit Margin-8 484.90
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios 6.29
Price to Cash Flow -
Price to Free Cash Flow -0.90
Cash Flow Per Share -3.36
Price to Tangible Book-0.42
Book Value per Share-1.94
Enterprise Value (in ths.)48 033
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)13.00
ROE last 12 Months 15.50
Return on Assets (5Y Avg) -116.53
ROA last 12 Months -58.49
Return on Capital (5Y Avg) -
ROC last 12 Months -
Return on invested Capital Q -
Return on invested Capital Y-
Assets Turnover0.10
Receivables Turnover4.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)4 785
Revenue per Share 0.13
Revenue Growth 3 Years 10.25
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.25-0.29-16.00
Q01 2018-0.35-0.3014.29
Q04 2017-0.41-0.44-7.32
Q03 2017-0.40-0.385.00
Q02 2017-0.46-0.4110.87
Q01 2017-0.46-0.444.35
Q04 2016-0.14-0.42-200.00
Q03 2016-0.42-0.412.38
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1542.31Positive
12/2018 QR-0.1640.74Positive
12/2018 FY-0.9216.36Positive
12/2019 FY-0.6313.70Positive
Next Report Date7th Nov 2018
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume69 197
Shares Outstanding (in ths.)34 540
Trades Count122
Dollar Volume52 943
Avg. Volume774 975
Avg. Weekly Volume241 567
Avg. Monthly Volume151 547
Avg. Quarterly Volume142 418

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

74%26%

Bearish Bullish

67%33%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x